Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JJH201501 Tablets vs Vortioxetine in Major Depressive Disorder
CTR20221362Phase 2Completed
- Sponsor
- Jiangsu Jibeier Pharmaceutical
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JJH201501 in major depressive disorder (MDD), sponsored by Jiangsu Jibeier Pharmaceutical. Started May 2022; status: completed.
02
Drugs
JJH201501
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20221362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221362.